SANSanofi IndiaINE058A01010SANOFISANOFI
There is no discussion about the security yet. Share your thoughts now!
Financials
Market Cap
$1.98B5Y beta
0.61EPS (TTM)
2.751Free Float
9.08MP/E ratio (TTM)
31.23Revenue (TTM)
$285.22MEBITDA (TTM)
$77.61MAnalyst Ratings
The price target is $111.83 and the stock is covered by 3 analysts.
Buy
2
Hold
0
Sell
1
Information
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.